142 related articles for article (PubMed ID: 31539872)
1. Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis.
Bolfi F; Neves AF; Boguszewski CL; Nunes-Nogueira VS
Eur J Endocrinol; 2019 Nov; 181(5):L5-L6. PubMed ID: 31539872
[No Abstract] [Full Text] [Related]
2. Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking.
Ayuk J; Sheppard MC; Clayton RN; Bates AS; Stewart PM
J Clin Endocrinol Metab; 2004 Nov; 89(11):5867-8; author reply 5868. PubMed ID: 15531556
[No Abstract] [Full Text] [Related]
3. The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery.
Wu TE; Lin HD; Lu RA; Wang ML; Chen RL; Chen HS
Growth Horm IGF Res; 2010 Dec; 20(6):411-5. PubMed ID: 20943425
[TBL] [Abstract][Full Text] [Related]
4. A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.
Sherlock M; Reulen RC; Aragon-Alonso A; Ayuk J; Clayton RN; Sheppard MC; Hawkins MM; Bates AS; Stewart PM
J Clin Endocrinol Metab; 2014 Feb; 99(2):478-85. PubMed ID: 24243636
[TBL] [Abstract][Full Text] [Related]
5. GH and mortality in acromegaly.
Sheppard MC
J Endocrinol Invest; 2005; 28(11 Suppl International):75-7. PubMed ID: 16625851
[TBL] [Abstract][Full Text] [Related]
6. IGF-I and mortality in patients with acromegaly.
Strasburger CJ
J Endocrinol Invest; 2005; 28(11 Suppl International):78-80. PubMed ID: 16625852
[TBL] [Abstract][Full Text] [Related]
7. Excess mortality in acromegaly.
Holdaway IM
Horm Res; 2007; 68 Suppl 5():166-72. PubMed ID: 18174739
[TBL] [Abstract][Full Text] [Related]
8. Predictors of morbidity and mortality in acromegaly: an Italian survey.
Arosio M; Reimondo G; Malchiodi E; Berchialla P; Borraccino A; De Marinis L; Pivonello R; Grottoli S; Losa M; Cannavò S; Minuto F; Montini M; Bondanelli M; De Menis E; Martini C; Angeletti G; Velardo A; Peri A; Faustini-Fustini M; Tita P; Pigliaru F; Borretta G; Scaroni C; Bazzoni N; Bianchi A; Appetecchia M; Cavagnini F; Lombardi G; Ghigo E; Beck-Peccoz P; Colao A; Terzolo M;
Eur J Endocrinol; 2012 Aug; 167(2):189-98. PubMed ID: 22596288
[TBL] [Abstract][Full Text] [Related]
9. Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis.
Bolfi F; Neves AF; Boguszewski CL; Nunes-Nogueira VS
Eur J Endocrinol; 2018 Jul; 179(1):59-71. PubMed ID: 29764907
[TBL] [Abstract][Full Text] [Related]
10. The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly.
Rizzo M; Montalto G; Rizvi AA; Christ ER
Angiology; 2012 Oct; 63(7):492-4. PubMed ID: 22371625
[No Abstract] [Full Text] [Related]
11. Letter re: Monitoring the response to treatment in acromegaly.
Ayuk J; Sheppard MC; Bates AS; Stewart PM
J Clin Endocrinol Metab; 2005 Aug; 90(8):4980. PubMed ID: 16087964
[No Abstract] [Full Text] [Related]
12. Biochemical monitoring of disease activity after surgery for acromegaly.
Shalet SM
J Clin Endocrinol Metab; 2004 Feb; 89(2):492-4. PubMed ID: 14764750
[No Abstract] [Full Text] [Related]
13. [Consensus on the change of criteria for cure of acromegaly during the last decade].
Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.
Ayuk J; Clayton RN; Holder G; Sheppard MC; Stewart PM; Bates AS
J Clin Endocrinol Metab; 2004 Apr; 89(4):1613-7. PubMed ID: 15070920
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly: are new tests needed?
Spada A
J Endocrinol Invest; 2003 Feb; 26(2):104-5. PubMed ID: 12739734
[No Abstract] [Full Text] [Related]
16. Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly?
Colao A; Lombardi G
J Clin Endocrinol Metab; 2008 Apr; 93(4):1181-2. PubMed ID: 18390816
[No Abstract] [Full Text] [Related]
17. Recent developments in the therapy of acromegaly.
Paisley AN; Trainer PJ
Expert Opin Investig Drugs; 2006 Mar; 15(3):251-6. PubMed ID: 16503762
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
Holdaway IM; Bolland MJ; Gamble GD
Eur J Endocrinol; 2008 Aug; 159(2):89-95. PubMed ID: 18524797
[TBL] [Abstract][Full Text] [Related]
19. The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
Karavitaki N; Fernandez A; Fazal-Sanderson V; Wass JA
Clin Endocrinol (Oxf); 2009 Dec; 71(6):840-5. PubMed ID: 19320648
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Monaghan PJ; Trainer PJ
Eur J Endocrinol; 2019 Nov; 181(5):C17-C20. PubMed ID: 31480015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
